title: Foetal programming reveals the dark side of AT(2)R.
authors.forename: Kent L
authors.initials: KL
authors.lastname: Thornburg
mesh_terms: D057912:Angiotensin II Type 2 Receptor Blockers / Q000494:pharmacology; D000818:Animals; D001665:Binding Sites; D005311:Fetal Hypoxia / Q000150:complications* / Q000235:genetics / Q000378:metabolism; D005865:Gestational Age; D006801:Humans; D015428:Myocardial Reperfusion Injury / Q000209:etiology* / Q000235:genetics / Q000378:metabolism / Q000503:physiopathology / Q000517:prevention & control; D009206:Myocardium / Q000378:metabolism* / Q000473:pathology; D011401:Promoter Regions, Genetic; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D044140:Receptor, Angiotensin, Type 1 / Q000235:genetics / Q000378:metabolism; D044139:Receptor, Angiotensin, Type 2 / Q000235:genetics / Q000378:metabolism*; D011965:Receptors, Glucocorticoid / Q000378:metabolism; D015854:Up-Regulation; D016277:Ventricular Function, Left; D017725:Ventricular Pressure
chemical_list: D057912:Angiotensin II Type 2 Receptor Blockers; D012333:RNA, Messenger; D044140:Receptor, Angiotensin, Type 1; D044139:Receptor, Angiotensin, Type 2; D011965:Receptors, Glucocorticoid